UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An HPV vaccine from India: broadening possibilities for cervical cancer control

The lancet oncology, 2023-12, Vol.24 (12), p.1288-1289

2023

Volltextzugriff (PDF)

Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis

The Journal of infectious diseases, 2016-05, Vol.213 (9), p.1444-1454

2016

Volltextzugriff (PDF)

Public health opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule

JNCI : Journal of the National Cancer Institute, 2023-03, Vol.115 (3), p.246-249

2023

Volltextzugriff (PDF)

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials

Vaccine, 2020-02, Vol.38 (6), p.1302-1314

2020

Volltextzugriff (PDF)

Screening for human papillomavirus‐driven oropharyngeal cancer: Considerations for feasibility and strategies for research

Cancer, 2018-05, Vol.124 (9), p.1859-1866

2018

Volltextzugriff (PDF)

Anal Cancer Incidence in the United States, 1977-2011: Distinct Patterns by Histology and Behavior

Cancer epidemiology, biomarkers & prevention, 2015-10, Vol.24 (10), p.1548-1556

2015

Volltextzugriff (PDF)

Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer

The New England journal of medicine, 2007-05, Vol.356 (19), p.1944-1956

2007

Volltextzugriff (PDF)

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

Cancer epidemiology, biomarkers & prevention, 2005-02, Vol.14 (2), p.467-475

2005

Volltextzugriff (PDF)

Real-World HPV Vaccine Effectiveness Studies: Guideposts for Interpretation of Current and Future Studies

JNCI : Journal of the National Cancer Institute, 2021-10, Vol.113 (10), p.1270-1271

2021

Volltextzugriff (PDF)

Oral human papillomavirus in healthy individuals: a systematic review of the literature

Sexually transmitted diseases, 2010-06, Vol.37 (6), p.386-391

2010

Volltextzugriff (PDF)

Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection

JNCI : Journal of the National Cancer Institute, 2016-01, Vol.108 (1), p.djv302

2016

Volltextzugriff (PDF)

Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus–driven oropharyngeal cancer and are associated with recurrence

Cancer, 2017-11, Vol.123 (22), p.4382-4390

2017

Volltextzugriff (PDF)

Cumulative incidence of anal cancer since HIV or AIDS diagnosis in the United States

JNCI : Journal of the National Cancer Institute, 2023-10, Vol.115 (10), p.1227-1230

2023

Volltextzugriff (PDF)

Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs

Vaccine, 2022-09, Vol.40 (37), p.5413-5432

2022

Volltextzugriff (PDF)

The Epidemiology of Oral HPV Infection among a Multinational Sample of Healthy Men

Cancer epidemiology, biomarkers & prevention, 2011-01, Vol.20 (1), p.172-182

2011

Volltextzugriff (PDF)

Different human papillomavirus types share early natural history transitions in immunocompetent women

International journal of cancer, 2022-09, Vol.151 (6), p.920-929

2022

Volltextzugriff (PDF)

Trends in incidence rates of head and neck squamous cell carcinomas overall and by potential relatedness to human papillomavirus, Costa Rica 2006 to 2015

International journal of cancer, 2023-05, Vol.152 (10), p.2052-2060

2023

Volltextzugriff (PDF)

The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents

JNCI : Journal of the National Cancer Institute, 2015-03, Vol.107 (3), p.1-4

2015

Volltextzugriff (PDF)

Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines

International journal of cancer, 2016-08, Vol.139 (3), p.510-517

2016

Volltextzugriff (PDF)

Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study

The Journal of infectious diseases, 2021-05, Vol.223 (9), p.1576-1581

2021

Volltextzugriff (PDF)

Associations of Oral α-, β-, and γ-Human Papillomavirus Types With Risk of Incident Head and Neck Cancer

JAMA oncology, 2016-05, Vol.2 (5), p.599

2016

Volltextzugriff (PDF)

Association Between Common Vaginal Infections and Cervical Non–Human Papillomavirus (HPV) 16/18 Infection in HPV-Vaccinated Women

The Journal of infectious diseases, 2021-02, Vol.223 (3), p.445-451

2021

Volltextzugriff (PDF)

Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosis

Cancer epidemiology, 2022-04, Vol.77, p.102117-102117, Article 102117

2022

Volltextzugriff (PDF)

Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica

Cancer discovery, 2011-10, Vol.1 (5), p.408-419

2011

Volltextzugriff (PDF)

Characterization of human papillomavirus antibodies in individuals with head and neck cancer

Cancer epidemiology, 2016-06, Vol.42, p.46-52

2016

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(132)

Publikationsform

Artikel
(144)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(115)
Life Sciences & Biomedicine
(112)
Humans
(109)
Female
(92)
Human Papillomavirus
(70)
Oncology
(59)
Adult
(54)
Papillomavirus Infections - Epidemiology
(41)
Young Adult
(41)
Papillomavirus Infections - Prevention & Control
(40)
Adolescent
(38)
Male
(38)
Middle Aged
(37)
Vaccines
(37)
Aged
(31)
Biological And Medical Sciences
(31)
Papillomavirus Infections - Virology
(31)
Infections
(30)
Medical Sciences
(29)
Cervical Cancer
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

An HPV vaccine from India: broadening possibilities for cervical cancer control

Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis

Public health opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials

Screening for human papillomavirus‐driven oropharyngeal cancer: Considerations for feasibility and strategies for research

Anal Cancer Incidence in the United States, 1977-2011: Distinct Patterns by Histology and Behavior

Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

Real-World HPV Vaccine Effectiveness Studies: Guideposts for Interpretation of Current and Future Studies

Oral human papillomavirus in healthy individuals: a systematic review of the literature

Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection

Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus–driven oropharyngeal cancer and are associated with recurrence

Cumulative incidence of anal cancer since HIV or AIDS diagnosis in the United States

Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs

The Epidemiology of Oral HPV Infection among a Multinational Sample of Healthy Men

Different human papillomavirus types share early natural history transitions in immunocompetent women

Trends in incidence rates of head and neck squamous cell carcinomas overall and by potential relatedness to human papillomavirus, Costa Rica 2006 to 2015

The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents

Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines

Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study

Associations of Oral α-, β-, and γ-Human Papillomavirus Types With Risk of Incident Head and Neck Cancer

Association Between Common Vaginal Infections and Cervical Non–Human Papillomavirus (HPV) 16/18 Infection in HPV-Vaccinated Women

Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosis

Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica

Characterization of human papillomavirus antibodies in individuals with head and neck cancer

Suchergebnisse filtern